ResearcherUniversitätsmedizin GöttingenActive in the last 2 years
Christoph Ammer‐Herrmenau
Matched on ORCID iD 0009-0009-2465-8927; OpenAlex author ID A5045794179. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 21
2022: 1 paper · 2023: 1 paper · 2024: 3 papers · 2025: none · 2026: 1 paper
Papers 6
- Benchmarking the Intratumoral Microbiome in Pancreatic Ductal Adenocarcinoma: A Longitudinal Assessment of Contamination Sources and Decontamination Strategies Last author DOI 10.64898/2026.08.24.746744↗
- Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic cancer models for therapeutic testing. Co-author DOI 10.1016/j.neo.2024.101002↗
- An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies. Co-author DOI 10.1053/j.gastro.2023.10.026↗
- A Concept for Mining Transitive Sequential Patterns from Pancreatic Cancer Patient Journeys. Co-author DOI 10.3233/shti240862↗
- Dynamics of intestinal and intratumoral microbiome signatures in genetically engineered mice and human pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.pan.2023.07.008↗
- The Microbiome in PDAC-Vantage Point for Future Therapies? Last author DOI 10.3390/cancers14235974↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Volker Ellenrieder · 5 shared papers, 2023–2026 · strength 1.06
- Paper Benchmarking the Intratumoral Microbiome in Pancreatic Ductal Adenocarcinoma: A Longitudinal Assessment of Contaminatio… DOI 10.64898/2026.08.24.746744↗
- Paper Dynamics of intestinal and intratumoral microbiome signatures in genetically engineered mice and human pancreatic ducta… DOI 10.1016/j.pan.2023.07.008↗
- Paper Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic can… DOI 10.1016/j.neo.2024.101002↗
- Albrecht Neeße · 5 shared papers, 2022–2026 · strength 1.05
- Paper Benchmarking the Intratumoral Microbiome in Pancreatic Ductal Adenocarcinoma: A Longitudinal Assessment of Contaminatio… DOI 10.64898/2026.08.24.746744↗
- Paper Dynamics of intestinal and intratumoral microbiome signatures in genetically engineered mice and human pancreatic ducta… DOI 10.1016/j.pan.2023.07.008↗
- Paper Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic can… DOI 10.1016/j.neo.2024.101002↗
- Elisabeth Heßmann · 3 shared papers, 2024 · strength 0.54
- Paper Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic can… DOI 10.1016/j.neo.2024.101002↗
- Paper A Concept for Mining Transitive Sequential Patterns from Pancreatic Cancer Patient Journeys. DOI 10.3233/shti240862↗
- Paper An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies. DOI 10.1053/j.gastro.2023.10.026↗
- Linh Dang · 2 shared papers, 2022–2026 · strength 0.49
- Nina Pfisterer · 2 shared papers, 2022–2023 · strength 0.40
- Shiv K. Singh · 2 shared papers, 2024 · strength 0.34
- Paper Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic can… DOI 10.1016/j.neo.2024.101002↗
- Paper An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies. DOI 10.1053/j.gastro.2023.10.026↗
- Ulrich Sax · 2 shared papers, 2024 · strength 0.33
- Alexander Otto König · 2 shared papers, 2024 · strength 0.33
- Robert G. Goetze · 1 shared paper, 2024 · strength 0.21
- Lisa Knoll · 1 shared paper, 2024 · strength 0.21
- Jonas Hügel · 1 shared paper, 2024 · strength 0.20
- Maria Ulisse · 1 shared paper, 2024 · strength 0.13
- Marie C. Hasselluhn · 1 shared paper, 2024 · strength 0.13
- Maximilian Reichert · 1 shared paper, 2024 · strength 0.13
- Stephan A. Hahn · 1 shared paper, 2024 · strength 0.13
- Steven A. Johnsen · 1 shared paper, 2024 · strength 0.13
- Lennart Versemann · 1 shared paper, 2024 · strength 0.13
- Feda H. Hamdan · 1 shared paper, 2024 · strength 0.13
- Carolin Schneider · 1 shared paper, 2024 · strength 0.13
- Günter Schneider · 1 shared paper, 2024 · strength 0.13
- Kenneth P. Olive · 1 shared paper, 2024 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.